Kilitch Drugs (India) Limited

Kilitch Drugs (India) Limited (KILITCH) is a micro-cap Healthcare company valued at ₹804 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Kilitch Drugs (India) Limited last traded at ₹231, down 2.20% on the day.

Recent developments

On 2026-03-24, the company announced a bonus share issue of 1:2, which may affect shareholder equity and liquidity. The promoter holding remained at 63.77% as of 2026-06-30, showing no significant change in ownership structure.

Financial performance

The company's business is growing, with annual revenue rising 18.9% and annual net profit increasing 18.0%. However, the latest quarter saw net profit fall 13.2% compared to the same quarter a year earlier, while revenue grew 4.0%, indicating a widening gap between revenue and profit growth.

Valuation multiples

The stock trades at 25.9 times earnings, a discount to the Healthcare median of 32.0, 2.29 times book value.

Things to watch

The company has not paid dividends despite reporting profits, which may signal financial conservatism or liquidity constraints. The net profit margin narrowed by 0.1 percentage points to 12.5%, and the latest quarter's net profit declined 13.2% compared to the same quarter a year earlier.

Where it stands

Kilitch Drugs India Ltd has shown strong revenue and profit growth over the past five years, but the latest quarter's net profit fell 13.2% compared to the same quarter a year earlier. The company's promoter holding remains at 63.77%, and it has not paid dividends despite repeated profits.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.